Praava Health, a startup aiming to transform health care in Bangladesh, is looking to raise $15 million in Series B funding, founder Sylvana Sinha tells Axios.
Why it matters: There is tremendous demand for trusted, quality health care in Bangladesh, yet the government has limited capacity to regulate the industry, Sinha says.
- There’s no primary care, no coordinated care, no insurance, unreliable outsourced diagnostics, perverse incentives for providers, and limited technology, among other issues, according to Praava’s investor report, viewed by Sarah.
- The large prevalence of adulterated and counterfeit medicine sales is problematic, accounting for 20% of all drug sales in Bangladesh, an industry association reported in 2020.
Read the full article in Axios.